Condition

Recurrent Ovarian Carcinoma clinical trials and research

• 12Clinical trials
• 1NIH research projects
• 3Countries

Newest Recurrent Ovarian Carcinoma clinical trials

All recruiting trials (12)

• Probiotic support for gut and vaginal microbiome during platinum chemotherapy for advanced or recurrent ovarian cancer

  This trial will test whether taking a probiotic during platinum chemotherapy helps keep the gut and vaginal microbiome healthier and may improve symptoms, quality of life, or cancer outcomes for people with advanced or recurrent ovarian cancer.

  Recruiting Early Phase 1 Ohio State University Comprehensive Cancer Center · Columbus, Ohio · NCT07144826

• Automated physical activity program for cancer patients

  This study is testing whether a personalized exercise program using wearable technology can help cancer patients be more active compared to regular exercise advice.

  Recruiting Roswell Park Cancer Institute · Buffalo, New York · NCT06855706

• Using MUC1-activated T cells to treat resistant ovarian cancer

  This study is testing a new treatment using specially designed immune cells to see if they can help people with tough-to-treat ovarian cancer feel better and improve their health.

  Recruiting Phase 1 Mayo Clinic · Scottsdale, Arizona · NCT06483048

• Investigating blood cancer risks in patients with ovarian and other solid tumors

  This study is trying to see if certain cancer treatments for ovarian and other solid tumors can increase the risk of blood cancers in patients.

  Recruiting University of Washington · Seattle, Washington · NCT06295965

• Surgery for recurrent ovarian cancer after chemotherapy

  This study tests if a specific type of surgery after chemotherapy can help women with recurrent ovarian cancer live longer and feel better.

  Recruiting The University of Hong Kong · Hong Kong · NCT06292286

• Targeted therapy for advanced solid tumors based on genetic testing

  This study is testing whether matching patients with advanced solid tumors to specific treatments based on their genetic makeup can improve their outcomes when standard options have failed.

  Recruiting at 437 sites Phase 2 National Cancer Institute (NCI) · Birmingham, Alabama and 483 other locations · NCT05564377

• Combining pembrolizumab and bevacizumab with an immune booster for recurrent ovarian cancer

  This study is testing a new combination of two cancer drugs, pembrolizumab and bevacizumab, with or without an immune booster, to see if it helps people with recurrent ovarian cancer feel better and live longer.

  Recruiting at 2 sites Phase 2 Roswell Park Cancer Institute · Buffalo, New York and 1 other locations · NCT05231122

• Combining APL-2 with Pembrolizumab and Bevacizumab for Recurrent Ovarian Cancer

  This study is testing if a new treatment combining APL-2 with pembrolizumab and bevacizumab can help people with recurrent ovarian cancer feel better and live longer compared to just using bevacizumab alone.

  Recruiting Phase 2 Roswell Park Cancer Institute · Buffalo, New York · NCT04919629

• Using abemaciclib to treat recurrent ovarian or endometrial cancer

  This study is testing if the drug abemaciclib can help people with recurrent ovarian or endometrial cancer stay cancer-free for at least 16 weeks.

  Recruiting Phase 2 Jonsson Comprehensive Cancer Center · Los Angeles, California · NCT04469764

• Combining ONC201 with Paclitaxel for Ovarian Cancer Treatment

  This study is testing if combining a new drug called ONC201 with paclitaxel can help people with hard-to-treat ovarian cancer feel better and live longer.

  Recruiting at 2 sites Phase 2 Barbara Ann Karmanos Cancer Institute · Detroit, Michigan and 1 other locations · NCT04055649

• Combining talazoparib with radiation therapy for recurrent gynecologic cancers

  This study is testing if combining a drug called talazoparib with radiation therapy can safely help people with recurrent gynecologic cancers feel better.

  Recruiting at 2 sites Phase 1 M.D. Anderson Cancer Center · Baltimore, Maryland and 1 other locations · NCT03968406

• Imaging with a new radioactive tracer for solid tumors

  This study is testing a new imaging method using a special radioactive tracer to see if it can help find tumor cells in patients with solid tumors like ovarian and breast cancers, while also looking at how safe it is and how it relates to certain genetic factors.

  Recruiting Phase 1 M.D. Anderson Cancer Center · Houston, Texas · NCT03604315

NIH-funded research (1)

Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.

• Combining trametinib and navitoclax to treat recurrent ovarian cancer

  This study is testing a new combination treatment for women with recurrent ovarian cancer that hasn't responded to standard therapies, aiming to see if it can help improve their outcomes.

  NIH research Dana-Farber Cancer Inst · Boston, United States · NIH-10895326

Related topics

Quick answers

How many Recurrent Ovarian Carcinoma clinical trials are recruiting right now?

12, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in United States (11 trials), Hong Kong (1 trial), Puerto Rico (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 5, Phase 1: 3, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →